Purple Biotech Ltd. logo

Purple Biotech Ltd. (PPBT)

Market Open
11 Aug, 18:15
NASDAQ (CM) NASDAQ (CM)
$
1. 55
+0.05
+3.3333%
$
207.13K Market Cap
- P/E Ratio
- Div Yield
82,269 Volume
-0.92 Eps
$ 1.5
Previous Close
Add Transaction
Day Range
1.43 1.69
Year Range
1.16 24
Want to track PPBT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Purple Biotech Ltd. (PPBT) Statistics

Valuation metrics

Market Cap 207.13K
Enterprise value -3.64M
Trailing P/E (ttm) -0.01
Forward P/E -3.07
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.63
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.49

Overview

Shares outstanding 1.86B
Float 1.85B
Shares short 10.48K
% Held by insiders 0.07%
% Held by institutions 0.11%
Average volume (10 days) 20.11K
Average volume (90 days) 308.51K

Price summary

52-Week low 1.16
52-Week high 24
Beta -0.57
50-Day moving average 1.39
200-Day moving average 4.26

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 2 Mar 2026

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin -
Operating margin -

Operational effectiveness

Return on assets -1.79%
Return on equity -1.23%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -59K
EBITDA -6.97M
Net income to common (ttm) -26.39M
Diluted EPS (ttm) -2.8
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 9.57M
Total cash per share (mrq) 0.7
Total debt (mrq) 244K
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 1.48%
Book value per share (mrq) 1.05

Cash Flow

Cash flow statement -5.66M
Levered free cash flow (LFCF) -54K